BIOGEN IDEC: Awaits Ruling on Classen Bid v. Junked Patent Suit

The U.S. Court of Appeals for the Federal Circuit has yet to rule on Classen Immunotherapies Inc.’s appeal from the dismissal of its patent infringement suit against Biogen Idec Inc,…